Cytogenetic confirmation of a positive NIPT result: Evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration

Expert Review of Molecular Diagnostics

Volumn 16, Issue 5, 2016, Pages 513-520

  Van Opstal, Diane ^a   Srebniak, Malgorzata I ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

amniocentesis; autosomal trisomy; chorionic villi; confined placental mosaicism; CPM; NIPT; non invasive prenatal diagnosis; prenatal diagnosis; trisomy 13; trisomy 18; trisomy 21

Indexed keywords

AMNIOCENTESIS; ARTICLE; CELL FREE SYSTEM; CHORION VILLUS; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CHROMOSOME MOSAICISM; CHROMOSOME STRUCTURE; CYTOGENETICS; CYTOTROPHOBLAST; EVIDENCE BASED PRACTICE; GESTATIONAL AGE; KARYOTYPE; MATERNAL PLASMA; MEDICAL LITERATURE; MESENCHYME CELL; NON INVASIVE PRENATAL TESTING; PARENT; PRENATAL SCREENING; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; TRISOMY 21; ABNORMALITIES; CHROMOSOME DISORDERS; EVIDENCE BASED MEDICINE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FETUS; GENETICS; HUMAN; KARYOTYPING; MOSAICISM; PATHOLOGY; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DIAGNOSIS; TIME FACTOR;

AMNIOCENTESIS; CHORIONIC VILLI; CHORIONIC VILLI SAMPLING; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; EVIDENCE-BASED MEDICINE; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FETUS; HUMANS; KARYOTYPING; MOSAICISM; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; TIME FACTORS;

EID: 84962567036     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2016.1152890     Document Type: Article

References (47)

1. Bianchi DW, Wilkins-Haug L. Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem. 2014;60(1):78-87.
2. Bayindir B, Dehaspe L, Brison N, et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet. 2015;23(10):1286-1293.
3. Lau TK, Jiang FM, Stevenson RJ, et al. Secondary findings from noninvasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn. 2013;33 (6):602-608.
4. Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated metaanalysis. Ultrasound Obstet Gynecol. 2015;45(3):249-266.
5. Van Opstal D, Srebniak MI, Polak J, et al. False negative NIPT results: risk figures for chromosomes 13, 18 and 21 based on chorionic villi results in 5967 cases and literature review. PLoS One. 2016;11(1): e0146794.
6. Brady P, Brison N, Van Den Bogaert K, et al. Clinical implementation of NIPT - technical and biological challenges. Clin Genet. 2015. doi:10.1111/cge.12598.
7. Faas BH, De Ligt J, Janssen I, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther. 2012;12(Suppl 1): S19-S26.
8. Srebniak MI, Diderich KE, Noomen P, et al. Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype. Ultrasound Obstet Gynecol. 2014;44(1):109-111.
9. Kalousek DK, Dill FJ. Chromosomal mosaicism confined to the placenta in human conceptions. Science. 1983;221(4611):665-667.
10. Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod. 2004;19(3):723-724.
11. Los FJ, Van Den Berg C, Van Opstal D, et al. Abnormal karyotypes in semi-direct chorionic villus preparations of women with different cytogenetic risks. Prenat Diagn. 1998;18(10):1023-1040.
12. Dondorp W, De Wert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Summary and recommendations. Eur J Hum Genet. Advanced online publication. 2015 Apr 1; doi:10.1038/ejhg.2015.56.
13. Papp C, Papp Z. Chorionic villus sampling and amniocentesis: what are the risks in current practice? Curr Opin Obstet Gynecol. 2003;15 (2):159-165.
14. Los FJ, Van Den Berg C, Wildschut HI, et al. The diagnostic performance of cytogenetic investigation in amniotic fluid cells and chorionic villi. Prenat Diagn. 2001;21(13):1150-1158.
15. Gibas LM, Grujic S, Barr MA, et al. A simple technique for obtaining high quality chromosome preparations from chorionic villus samples using FdU synchronization. Prenat Diagn. 1987;7 (5):323-327.
16. Smidt-Jensen S, Christensen B, Lind AM. Chorionic villus culture for prenatal diagnosis of chromosome defects: reduction of the longterm cultivation time. Prenat Diagn. 1989;9(5):309-319.
17. Crane JP, Cheung SW. An embryogenic model to explain cytogenetic inconsistencies observed in chorionic villus versus fetal tissue. Prenat Diagn. 1988;8(2):119-129.
18. Bianchi DW, Wilkins-Haug LE, Enders AC, et al. Origin of extraembryonic mesoderm in experimental animals: relevance to chorionic mosaicism in humans. Am J Med Genet. 1993;46(5):542-550.
19. Pittalis MC, Dalpra L, Torricelli F, et al. The predictive value of cytogenetic diagnosis after CVS based on 4860 cases with both direct and culture methods. Prenat Diagn. 1994;14(4):267-278.
20. Wolstenholme J. Confined placental mosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization. Prenat Diagn. 1996;16 (6):511-524.
21. Battaglia P, Baroncini A, Mattarozzi A, et al. Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosis. Prenat Diagn. 2014;34(8):739-747.
22. Hahnemann JM, Vejerslev LO. Accuracy of cytogenetic findings on chorionic villus sampling (CVS)-diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992. Prenat Diagn. 1997;17(9):801-820.
23. Hahnemann JM, Vejerslev LO. European collaborative research on mosaicism in CVS (EUCROMIC)-fetal and extrafetal cell lineages in 192 gestations with CVS mosaicism involving single autosomal trisomy. Am J Med Genet. 1997;70(2):179-187.
24. Karampetsou E, Morrogh D, Ballard T, et al. Confined placental mosaicism: implications for fetal chromosomal analysis using microarray comparative genomic hybridization. Prenat Diagn. 2014;34(1):98-101.
25. Kooper AJ, Faas BH. Comment on 'confined placental mosaicism: implications for fetal chromosomal analysis using microarray comparative genomic hybridization'. Prenat Diagn. 2014;34(8):815-816.
26. European cytogenetic guidelines. E.C.A.-European Cytogenetics Association Newsletter. 2012 Jul;30:11-19. Available from: http:// www.e-c-a.eu/files/downloads/Guidelines/Specific-Constitutional- Guidelines-NL30.pdf.
27. ACC CVS database 2005. [Internet]. [cited 2005 Nov 4]. Available from: http://acccvs.ncl.ac.uk//.
28. Wolstenholme J, Emslie JB, Connors S. Association of clinical cytogeneticists chorion villus sampling database 1987-2000. Prenat Diagn. 2006;26(5):420-427.
29. Grati FR, Grimi B, Frascoli G, et al. Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi. Eur J Hum Genet. 2006;14 (3):282-288.
30. Grati FR, Malvestiti F, Ferreira JC, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014;16(8):620-624.
31. Van Opstal D, Van Den Berg C, Galjaard RJ, et al. Follow-up investigations in uncultured amniotic fluid cells after uncertain cytogenetic results. Prenat Diagn. 2001;21(2):75-80.
32. Grati FR, Bajaj K, Malvestiti F, et al. The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure. Prenat Diagn. 2015;35 (10):994-998.
33. Van Den Berg C, Van Opstal D, Polak-Knook J, et al. (Potential) falsenegative diagnoses in chorionic villi and a review of the literature. Prenat Diagn. 2006;26(5):401-408.
34. Mann K, Hills A, Donaghue C, et al. Quantitative fluorescence PCR analysis of >40, 000 prenatal samples for the rapid diagnosis of trisomies 13, 18 and 21 and monosomy X. Prenat Diagn. 2012;32 (12):1197-1204.
35. Conlin LK, Thiel BD, Bonnemann CG, et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum Mol Genet. 2010;19 (7):1263-1275.
36. Smith K, Lowther G, Maher E, et al. The predictive value of findings of the common aneuploidies, trisomies 13, 18 and 21, and numerical sex chromosome abnormalities at CVS: experience from the ACC U.K. Collaborative study. Association of clinical cytogeneticists prenatal diagnosis working party. Prenat Diagn. 1999;19(9):817-826.
37. Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem. 2014;60 (1):251-259.
38. Kalousek DK, Howard-Peebles PN, Olson SB, et al. Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism. Prenat Diagn. 1991;11(10):743-750.
39. Goldberg JD, Porter AE, Golbus MS. Current assessment of fetal losses as a direct consequence of chorionic villus sampling. Am J Med Genet. 1990;35(2):174-177.
40. Johnson A, Wapner RJ, Davis GH, et al. Mosaicism in chorionic villus sampling: an association with poor perinatal outcome. Obstet Gynecol. 1990;75(4):573-577.
41. Van Opstal D, Van Den Berg C, Deelen WH, et al. Prospective prenatal investigations on potential uniparental disomy in cases of confined placental trisomy. Prenat Diagn. 1998;18(1):35-44.
42. Schuring-Blom GH, Keijzer M, Jakobs ME, et al. Molecular cytogenetic analysis of term placentae suspected of mosaicism using fluorescence in situ hybridization. Prenat Diagn. 1993;13(8):671-679.
43. Amant F, Verheecke M, Wlodarska I, et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 2015;1(6):814-819.
44. Korenromp MJ, Christiaens GC, Van Den Bout J, et al. Long-term psychological consequences of pregnancy termination for fetal abnormality: a cross-sectional study. Prenat Diagn. 2005;25 (3):253-260.
45. Van Den Berg C, Van Opstal D, Brandenburg H, et al. Accuracy of abnormal karyotypes after the analysis of both short- and longterm culture of chorionic villi. Prenat Diagn. 2000;20(12):956-969.
46. Straver R, Sistermans EA, Holstege H, et al. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res. 2014;42(5):e31.
47. Straver R, Sistermans EA, Reinders MJ. Introducing WISECONDOR for noninvasive prenatal diagnostics. Expert Rev Mol Diagn. 2014;14(5):513-515.